Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
23 October, 2018 15:25 IST
CARE Ratings upgrades Manappuram Finance to AA stable
Source: IRIS | 14 Aug, 2017, 03.49PM
Comments  |  Post Comment

CARE Ratings has upgraded the long-term credit rating of Manappuram Finance (MAFIL) to CARE AA (double A) stable from CARE AA- (double A minus) stable. The revised credit rating applies to the Rs. 56.80 billion long term bank facilities of the company and its NCD issues aggregating to Rs 5.80 billion.

A  press release issued by CARE Ratings said that the revision in the long term rating factors in the significant improvement in financial performance of the company during FY17, primarily supported by its focus on shorter tenure loans leading to lesser under recovery. The profitability in FY17 is also aided by growth in AUM and decline in the cost of borrowings in trend with industry.

The release noted the long track record and the established market position of MAFIL as one of the leading players in the gold loan industry in India, experienced promoters & management team, comfortable capitalization level and liquidity position and adequate risk management & management information systems in place. 

The ratings are, however, constrained by product concentration on a single asset class, exposure to price of gold, geographical concentration of the loan portfolio and moderation in asset quality during FY17 on account of transition from 120 dpd (days past due) to 90 dpd.

Earlier, on July 14, 2017, Brickwork Ratings had upgraded the long-term credit rating of Manappuram (Q,N,C,F)* Finance (MAFIL) to BWR AA (double A) stable from BWR AA- (double A minus) stable. The revised credit rating applies to the Rs 547.0 million NCD issue of the company.

Shares of the company gained Rs 2.95, or 3.44%, to trade at  Rs 88.80.  The total volume of shares traded  was  739,382 at the BSE (3.34 p.m., Monday).



Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Zydus receives final approval from USFDA for Clobazam Tablets - 23-Oct-2018 15:01
Ahluwalia Contracts wins new orders of worth Rs 5.38 bn - 23-Oct-2018 11:58
PNB Housing Finance raises Rs 17.75 bn through commercial papers - 23-Oct-2018 10:22
White Organic Agro bags additional orders from Innovative Cuisine - 23-Oct-2018 10:16
Himachal Futuristic Communications secures order worth Rs 3.66 bn - 23-Oct-2018 10:07
Lupin gets nod for generic Triamcinolone Acetonide ointment - 23-Oct-2018 10:00
ITD Cementation India bags orders worth Rs 10.66 bn - 23-Oct-2018 09:35
Biocon, Mylan announce positive CHMP Opinion for Ogivri - 22-Oct-2018 10:28
Lupin announces positive CHMP opinion for NaMuscla - 22-Oct-2018 09:51
Tejas Networks bags Rs 1.11 bn order from Sterlite Technologies - 22-Oct-2018 09:45
Alembic Pharma' JV completes USFDA inspection of Karakhadi unit - 22-Oct-2018 09:41
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer